Skip to content

Biodesix Inc

BDSX· NasdaqCore metricsCIK 1439725

Medical laboratories28 peers

Last sale
Nov 12, 2026 · -3.78%
Market cap
$108.78M
11.09M shares
Filings
602
$24.04M
Q3 2026+24.1% FY25 yoy
-$8.03M
Q3 2026N/M FY25 yoy
-$6.11M
Q3 2026N/M FY25 yoy
-$19.77M
Q3 2026derivedN/M FY25 yoy
-$0.75
Q3 2026N/M FY25 yoy
$28.41M
Q3 2026−27.7% FY25 yoy
$108.78M
—
1.0×
12.5×
-17.53%
—

Twelve months to Sep 30, 2026 · derived

Price

$9.81+17.63%+$1.47past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$88.50MFY 2025
$88.50M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$88,499,000reported
FY 20242024-12-31$71,323,000reported
FY 20232023-12-31$49,087,000reported
FY 20222022-12-31$38,212,000reported
FY 20212021-12-31$54,506,000reported
FY 20202020-12-31$45,557,000reported
FY 20192019-12-31$24,552,000reported

Segments

Products
Revenue by Products, FY2019 to FY2025FY2019Diagnostic Tests · FY2019 · $17.32MServices · FY2019 · $7.24MFY2020Diagnostic Tests · FY2020 · $40.92MCOVID-19 Test Revenue · FY2020 · $28.30MLung Diagnostic Revenue · FY2020 · $12.60MServices · FY2020 · $4.64MFY2021Diagnostic Tests · FY2021 · $48.94MServices · FY2021 · $5.57MFY2022Diagnostic Tests · FY2022 · $34.54MBiopharma Services and Other · FY2022 · $3.67MServices · FY2022 · $3.67MFY2023Diagnostic Tests · FY2023 · $45.19MDevelopment Services · FY2023 · $3.90MBiopharma Services and Other · FY2023 · $3.90MLung Diagnostic Testing · FY2023 · $45.19MFY2024Diagnostic Tests · FY2024 · $64.71MDevelopment Services · FY2024 · $6.62MLung Diagnostic Testing · FY2024 · $64.71MFY2025Diagnostic Tests · FY2025 · $79.20MDevelopment Services · FY2025 · $9.30M
LineFY2025ShareChange
Diagnostic Tests$79.20M89%+22.4%
Development Services$9.30M11%+40.6%
Biopharma Services and Other———
COVID-19 Test Revenue———
Lung Diagnostic Revenue———
Lung Diagnostic Testing———
Services———
Total$88.50M

From the 10-K filed Feb 26, 2026BDSX

Medical laboratories

Biodesix Inc is the 15th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Biodesix Inc · CIK 1439725 · Engraved from SEC EDGAR